High prevalence of ventricular repolarization abnormalities in people carrying TGFβR2 mutations

[1]  Klaus Romero,et al.  CredibleMeds.org: What does it offer? , 2018, Trends in cardiovascular medicine.

[2]  S. Lemaire,et al.  International Registry of Patients Carrying TGFBR1 or TGFBR2 MutationsCLINICAL PERSPECTIVE , 2016 .

[3]  Andrea Mazzanti,et al.  2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. , 2016, Revista espanola de cardiologia.

[4]  F. Tubach,et al.  Marfan Sartan: a randomized, double-blind, placebo-controlled trial. , 2015, European heart journal.

[5]  Sabino Iliceto,et al.  Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death , 2015, Circulation.

[6]  S. Priori,et al.  Genetic modulators of the phenotype in the long QT syndrome: state of the art and clinical impact. , 2015, Current opinion in genetics & development.

[7]  V. Aboyans,et al.  [2014 ESC Guidelines on the diagnosis and treatment of aortic diseases]. , 2015, Kardiologia polska.

[8]  J. Cross,et al.  Role of Mutation and Pharmacologic Block of Human KCNH2 in Vasculogenesis and Fetal Mortality: Partial Rescue by Transforming Growth Factor-&bgr; , 2015, Circulation. Arrhythmia and electrophysiology.

[9]  Beatriz Trenor,et al.  Electrophysiological and Structural Remodeling in Heart Failure Modulate Arrhythmogenesis. 1D Simulation Study , 2014, PloS one.

[10]  P. Robinson,et al.  Observational Cohort Study of Ventricular Arrhythmia in Adults with Marfan Syndrome Caused by FBN1 Mutations , 2013, PloS one.

[11]  C. Tracy,et al.  HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. , 2013, Heart rhythm.

[12]  S. Willems,et al.  Prospective risk stratification of sudden cardiac death in Marfan's syndrome. , 2013, International journal of cardiology.

[13]  M. Halushka,et al.  TGFβ Receptor Mutations Impose a Strong Predisposition for Human Allergic Disease , 2013, Science Translational Medicine.

[14]  M. Enriquez-Sarano,et al.  Malignant bileaflet mitral valve prolapse syndrome in patients with otherwise idiopathic out-of-hospital cardiac arrest. , 2013, Journal of the American College of Cardiology.

[15]  Yanjie Lu,et al.  Arsenic-induced interstitial myocardial fibrosis reveals a new insight into drug-induced long QT syndrome. , 2012, Cardiovascular research.

[16]  D. Milewicz,et al.  TGFBR2 mutations alter smooth muscle cell phenotype and predispose to thoracic aortic aneurysms and dissections. , 2010, Cardiovascular research.

[17]  Laurence Faivre,et al.  The revised Ghent nosology for the Marfan syndrome , 2010, Journal of Medical Genetics.

[18]  P. Ravaud,et al.  Comparison of Clinical Presentations and Outcomes Between Patients With TGFBR2 and FBN1 Mutations in Marfan Syndrome and Related Disorders , 2009, Circulation.

[19]  P. Kwok,et al.  Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease. , 2009, Heart rhythm.

[20]  E. W. Hancock,et al.  AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the , 2009, Journal of the American College of Cardiology.

[21]  S. Priori,et al.  High Efficacy of β-Blockers in Long-QT Syndrome Type 1: Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of β-Blocker Treatment “Failures” , 2009, Circulation.

[22]  Wolfram Kress,et al.  A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2 , 2005, Nature Genetics.

[23]  Yusuke Nakamura,et al.  Heterozygous TGFBR2 mutations in Marfan syndrome , 2004, Nature Genetics.

[24]  B. McCrindle,et al.  General cardiology: abstractLong-term outcome in patients with Marfan syndrome: is aortic dissection the only cause of sudden death?☆ , 2003 .

[25]  L. Jordaens,et al.  Cardiac Effects of Chronic Oral Beta‐Blockade: , 2002, Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc.

[26]  G. Breithardt,et al.  Life-threatening Arrhythmias Genotype-phenotype Correlation in the Long-qt Syndrome : Gene-specific Triggers for Genotype-phenotype Correlation in the Long-qt Syndrome Gene-specific Triggers for Life-threatening Arrhythmias , 2022 .

[27]  I. Kaitila,et al.  Abnormal ambulatory electrocardiographic findings in patients with the Marfan syndrome , 1997, Journal of internal medicine.

[28]  R E Pyeritz,et al.  Revised diagnostic criteria for the Marfan syndrome. , 1996, American journal of medical genetics.

[29]  J. Weissenbach,et al.  A second locus for Marfan syndrome maps to chromosome 3p24.2–p25 , 1994, Nature Genetics.

[30]  T. Graham.  Comparison of Clinical Presentations and Outcomes Between Patients With TGFBR2 and FBN1 Mutations in Marfan Syndrome and Related Disorders , 2011 .

[31]  S. Priori,et al.  High Efficacy of (cid:1) -Blockers in Long-QT Syndrome Type 1 Contribution of Noncompliance and QT-Prolonging Drugs to the Occurrence of (cid:1) -Blocker Treatment “Failures” , 2009 .

[32]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[33]  P W Macfarlane,et al.  Effects of age, sex, and race on ECG interval measurements. , 1994, Journal of electrocardiology.

[34]  E. T. Murphy.  What Does It Offer , 1962 .